CytoDyn Inc. Quarterly Common Stock, Shares Authorized from Q1 2010 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
CytoDyn Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q1 2010 to Q4 2024.
  • CytoDyn Inc. Common Stock, Shares Authorized for the quarter ending November 30, 2024 was 1.75B shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 1.75B 0 0% Nov 30, 2024 10-Q 2025-01-14
Q3 2024 1.75B +400M +29.6% Aug 31, 2024 10-Q 2024-10-15
Q2 2024 1.75B 0 0% May 31, 2024 10-Q 2025-01-14
Q1 2024 1.75B +400M +29.6% Feb 29, 2024 10-Q 2024-04-15
Q4 2023 1.75B +400M +29.6% Nov 30, 2023 10-Q 2024-01-16
Q3 2023 1.35B 0 0% Aug 31, 2023 10-Q 2023-10-23
Q2 2023 1.75B +400M +29.6% May 31, 2023 10-K 2024-08-15
Q1 2023 1.35B +350M +35% Feb 28, 2023 10-Q 2023-04-10
Q4 2022 1.35B 0 0% Nov 30, 2022 10-Q 2023-01-09
Q3 2022 1.35B +550M +68.8% Aug 31, 2022 10-K 2023-09-14
Q2 2022 1.35B +350M +35% May 31, 2022 10-K 2023-09-14
Q1 2022 1B +200M +25% Feb 28, 2022 10-Q 2022-04-11
Q4 2021 1.35B +550M +68.8% Nov 30, 2021 10-Q 2023-01-09
Q3 2021 800M 0 0% Aug 31, 2021 10-Q 2021-10-12
Q2 2021 1B +200M +25% May 31, 2021 10-K 2022-08-15
Q1 2021 800M +100M +14.3% Feb 28, 2021 10-Q 2021-04-14
Q4 2020 800M +100M +14.3% Nov 30, 2020 10-Q 2021-01-08
Q3 2020 800M +100M +14.3% Aug 31, 2020 10-Q 2020-10-09
Q2 2020 800M +100M +14.3% May 31, 2020 10-K 2021-07-30
Q1 2020 700M +100M +16.7% Feb 29, 2020 10-Q 2020-04-09
Q4 2019 700M +100M +16.7% Nov 30, 2019 10-Q 2020-01-09
Q3 2019 700M +250M +55.6% Aug 31, 2019 10-Q 2019-10-08
Q2 2019 700M +250M +55.6% May 31, 2019 10-K 2020-08-14
Q1 2019 600M +225M +60% Feb 28, 2019 10-Q 2019-04-09
Q4 2018 600M +225M +60% Nov 30, 2018 10-Q 2019-01-09
Q3 2018 450M +100M +28.6% Aug 31, 2018 10-Q 2018-10-09
Q2 2018 450M +100M +28.6% Jun 7, 2018 10-Q 2019-04-09
Q1 2018 375M +25M +7.14% Feb 28, 2018 10-Q 2018-04-09
Q4 2017 375M +25M +7.14% Nov 30, 2017 10-Q 2018-01-08
Q3 2017 350M 0 0% Aug 31, 2017 10-Q 2017-10-10
Q2 2017 350M +100M +40% May 31, 2017 10-K 2018-07-27
Q1 2017 350M +100M +40% Feb 28, 2017 10-Q 2017-04-13
Q4 2016 350M +150M +75% Nov 30, 2016 10-Q 2017-01-13
Q3 2016 350M +150M +75% Aug 31, 2016 10-Q 2016-10-12
Q2 2016 250M +150M +150% May 31, 2016 10-K 2017-07-20
Q1 2016 250M +150M +150% Mar 18, 2016 10-K 2018-07-27
Q4 2015 200M +100M +100% Nov 30, 2015 10-Q 2016-01-11
Q3 2015 200M +100M +100% Aug 31, 2015 10-Q 2015-10-09
Q2 2015 100M 0 0% May 31, 2015 10-K 2016-07-19
Q1 2015 100M 0 0% Feb 28, 2015 10-Q 2015-04-10
Q4 2014 100M 0 0% Nov 30, 2014 10-Q 2015-01-12
Q3 2014 100M 0 0% Aug 31, 2014 10-Q 2014-10-10
Q2 2014 100M 0 0% May 31, 2014 10-K 2015-07-10
Q1 2014 100M 0 0% Feb 28, 2014 10-Q 2014-04-11
Q4 2013 100M 0 0% Nov 30, 2013 10-Q 2014-01-13
Q3 2013 100M 0 0% Aug 31, 2013 10-Q 2013-10-15
Q2 2013 100M 0 0% May 31, 2013 10-K 2014-07-10
Q1 2013 100M 0 0% Feb 28, 2013 10-Q 2013-04-12
Q4 2012 100M 0 0% Nov 30, 2012 10-Q 2013-01-14
Q3 2012 100M 0 0% Aug 31, 2012 10-Q/A 2012-11-08
Q2 2012 100M 0 0% May 31, 2012 10-K 2013-08-29
Q1 2012 100M Feb 29, 2012 10-Q 2012-04-16
Q4 2011 100M Nov 30, 2011 10-Q 2012-01-17
Q3 2011 100M Aug 31, 2011 10-Q/A 2011-11-30
Q2 2011 100M May 31, 2011 10-K 2012-08-22
Q1 2010 100M Apr 30, 2010 10-Q 2020-01-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.